(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 3.06% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.15%.
Revvity's revenue in 2025 is $2,798,467,000.On average, 5 Wall Street analysts forecast RVTY's revenue for 2025 to be $330,548,243,292, with the lowest RVTY revenue forecast at $329,727,378,006, and the highest RVTY revenue forecast at $331,492,841,948. On average, 5 Wall Street analysts forecast RVTY's revenue for 2026 to be $341,726,729,181, with the lowest RVTY revenue forecast at $339,824,531,740, and the highest RVTY revenue forecast at $343,995,019,540.
In 2027, RVTY is forecast to generate $363,236,603,271 in revenue, with the lowest revenue forecast at $360,165,090,659 and the highest revenue forecast at $367,960,525,132.